identified 5 prognostic anoikis-related genes (CHEK2, PDK4, ZNF304, SNAI2, SRC) to establish a risk-predictive model for clear cell renal cell carcinoma (33), which all exhibited great predictive performance and implemented as a stratification factor for individualized treatment. This evidence concerns the gene ZNF304 and clear cell renal carcinoma.